TCT-892 Predictors of “futility” with transcutaneous aortic valve replacement therapy (TAVR): An analysis from the PARTNER randomized trial
暂无分享,去创建一个
M. Mack | A. Kirtane | M. Leon | S. Kapadia | S. Arnold | V. Thourani | Ke Xu | P. Green | N. Beohar | A. Zajarías | Maria C. Alu | D. Cohen